Inger Njølstad

45.2k total citations · 2 hit papers
214 papers, 9.8k citations indexed

About

Inger Njølstad is a scholar working on Cardiology and Cardiovascular Medicine, Public Health, Environmental and Occupational Health and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Inger Njølstad has authored 214 papers receiving a total of 9.8k indexed citations (citations by other indexed papers that have themselves been cited), including 101 papers in Cardiology and Cardiovascular Medicine, 52 papers in Public Health, Environmental and Occupational Health and 33 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Inger Njølstad's work include Blood Pressure and Hypertension Studies (39 papers), Venous Thromboembolism Diagnosis and Management (29 papers) and Health Promotion and Cardiovascular Prevention (24 papers). Inger Njølstad is often cited by papers focused on Blood Pressure and Hypertension Studies (39 papers), Venous Thromboembolism Diagnosis and Management (29 papers) and Health Promotion and Cardiovascular Prevention (24 papers). Inger Njølstad collaborates with scholars based in Norway, United States and United Kingdom. Inger Njølstad's co-authors include Tom Wilsgaard, Ellisiv B. Mathiesen, Maja‐Lisa Løchen, Egil Arnesen, Henrik Schirmer, Kaare Harald Bønaa, Sigrid K. Brækkan, John‐Bjarne Hansen, Anne Elise Eggen and E. B. Mathiesen and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Circulation.

In The Last Decade

Inger Njølstad

206 papers receiving 9.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Homocysteine Lowering and Cardiovascular Events after Acute Myocardial Infarction

2006 1.0k citations Kaare Harald Bønaa, Inger Njølstad et al. profile →
Cohort profile: The Tromso Study

2011 542 citations Anne Elise Eggen, E. B. Mathiesen et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Inger Njølstad	3.5k	1.3k	1.3k	1.3k	1.2k	214	9.8k
Tom Wilsgaard	3.5k 1.0×	2.4k 1.8×	2.0k 1.6×	895 0.7×	1.8k 1.5×	360	13.5k
Hideki Origasa	3.4k 1.0×	2.3k 1.8×	704 0.5×	2.1k 1.7×	923 0.8×	254	9.6k
Peter Riis Hansen	5.8k 1.7×	2.1k 1.6×	470 0.4×	1.3k 1.0×	612 0.5×	334	14.1k
Liping Zhang	2.7k 0.8×	1.8k 1.4×	668 0.5×	738 0.6×	2.4k 2.0×	56	10.0k
T W Meade	2.0k 0.6×	1.6k 1.3×	794 0.6×	1.3k 1.0×	2.1k 1.8×	132	8.3k
Stefan Agewall	6.1k 1.8×	2.8k 2.2×	551 0.4×	1.1k 0.9×	1.0k 0.9×	228	10.9k
Chuanzhu Yan	2.7k 0.8×	1.7k 1.3×	646 0.5×	717 0.6×	2.3k 2.0×	7	9.1k
Xiao Shang	2.7k 0.8×	1.7k 1.3×	647 0.5×	719 0.6×	2.3k 2.0×	18	9.1k
Eric Leip	9.9k 2.8×	1.3k 1.0×	1.4k 1.1×	1.5k 1.2×	1.1k 0.9×	117	14.6k
Suzanne E. Judd	3.5k 1.0×	773 0.6×	2.8k 2.1×	768 0.6×	912 0.8×	436	12.0k

Countries citing papers authored by Inger Njølstad

Since Specialization

Citations

This map shows the geographic impact of Inger Njølstad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inger Njølstad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inger Njølstad more than expected).

Fields of papers citing papers by Inger Njølstad

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inger Njølstad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inger Njølstad. The network helps show where Inger Njølstad may publish in the future.

Co-authorship network of co-authors of Inger Njølstad

This figure shows the co-authorship network connecting the top 25 collaborators of Inger Njølstad. A scholar is included among the top collaborators of Inger Njølstad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inger Njølstad. Inger Njølstad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wilsgaard, Tom, Jocasta Ball, Maja‐Lisa Løchen, et al.. (2025). Heart Failure in Atrial Fibrillation Subtypes in Women and Men in the Tromsø Study. JACC Advances. 4(2). 101556–101556. 1 indexed citations

Albrektsen, Grethe, Tom Wilsgaard, Ivar Heuch, et al.. (2023). Lipid Levels During Adult Lifetime in Men and Women With and Without a Subsequent Incident Myocardial Infarction: A Longitudinal Analysis of Data From the Tromsø Study 1974 to 2016. Journal of the American Heart Association. 12(14). e030010–e030010. 4 indexed citations

Ariansen, Inger, Tove Aminda Hanssen, Knut Tore Lappegård, et al.. (2022). Achievements of primary prevention targets in individuals with high risk of cardiovascular disease: an 8-year follow-up of the Tromsø study. European Heart Journal Open. 2(5). oeac061–oeac061. 3 indexed citations

Gerdts, Eva, Jocasta Ball, Bjarne K. Jacobsen, et al.. (2022). Sex-specific time trends in incident atrial fibrillation and the contribution of risk factors: the Tromsø Study 1994–2016. European Journal of Preventive Cardiology. 30(1). 72–81. 9 indexed citations

Morelli, Vânia M., Maja‐Lisa Løchen, Inger Njølstad, et al.. (2022). Joint effect of myocardial infarction and obesity on the risk of venous thromboembolism: The Tromsø Study. Journal of Thrombosis and Haemostasis. 20(10). 2342–2349. 4 indexed citations

Lindekleiv, Haakon, Christopher Sivert Nielsen, Jan Mannsverk, et al.. (2021). Low pain tolerance is associated with coronary angiography, coronary artery disease, and mortality: The TROMSO study. Duo Research Archive (University of Oslo). 3 indexed citations

Ball, Jocasta, Maja‐Lisa Løchen, Tom Wilsgaard, et al.. (2021). Sex-Specific Associations between Blood Pressure and Risk of Atrial Fibrillation Subtypes in the Tromsø Study. Journal of Clinical Medicine. 10(7). 1514–1514. 9 indexed citations

Wilsgaard, Tom, et al.. (2021). Trends in known and undiagnosed diabetes, HbA1c levels, cardiometabolic risk factors and diabetes treatment target achievement in repeated cross-sectional surveys: the population-based Tromsø Study 1994–2016. BMJ Open. 11(3). e041846–e041846. 11 indexed citations

Hopstock, Laila Arnesdatter, Bente Morseth, Sarah Cook, et al.. (2021). Treatment target achievement after myocardial infarction and ischaemic stroke: cardiovascular risk factors, medication use, and lifestyle: the Tromsø Study 2015–16. European Journal of Preventive Cardiology. 29(2). 362–370. 7 indexed citations

10.

Hopstock, Laila Arnesdatter, et al.. (2019). Folkehelserapport: Den sjuende Tromsøundersøkelsen 2015-16. Septentrio Academic Publishing (University of Tromsø). 2 indexed citations

11.

Wilsgaard, Tom, David A. Leon, Geir Heggelund, et al.. (2019). Left atrial diameter, left ventricle filling indices, and association with all‐cause mortality: Results from the population‐based Tromsø Study. Echocardiography. 36(3). 439–450. 9 indexed citations

12.

Njølstad, Inger, Ellisiv B. Mathiesen, Henrik Schirmer, & Dag S. Thelle. (2016). The Tromsø study 1974–2016: 40 years of cardiovascular research. Scandinavian Cardiovascular Journal. 50(5-6). 276–281. 22 indexed citations

13.

Mannsverk, Jan, Tom Wilsgaard, Ellisiv B. Mathiesen, et al.. (2015). Trends in Modifiable Risk Factors Are Associated With Declining Incidence of Hospitalized and Nonhospitalized Acute Coronary Heart Disease in a Population. Circulation. 133(1). 74–81. 118 indexed citations

14.

Brækkan, Sigrid K., E. B. Mathiesen, Inger Njølstad, Tom Wilsgaard, & J.-B. Hansen. (2009). Hematocrit and risk of venous thromboembolism in a general population. The Tromso study. Haematologica. 95(2). 270–275. 157 indexed citations

15.

Selmer, Randi, Anja Schou Lindman, Aage Tverdal, et al.. (2008). Modell for estimering av kardiovaskulær risiko i Norge. Tidsskrift for Den Norske Laegeforening. 6 indexed citations

16.

Mathiesen, Ellisiv B., Inger Njølstad, & Oddmund Joakimsen. (2007). Risikofaktorer for hjerneslag. Tidsskrift for Den Norske Laegeforening. 1 indexed citations

17.

Njølstad, Inger. (2006). Innføring i epidemiologi. Tidsskrift for Den Norske Laegeforening. 1 indexed citations

18.

Njølstad, Inger & Maja‐Lisa Løchen. (2002). [Are results of large clinical drug trials valid for both men and women?].. PubMed. 122(12). 1210–2.

19.

Augensen, Kåre, et al.. (2002). Er antibiotikaprofylakse ved keisersnitt nødvendig. Tidsskrift for Den Norske Laegeforening. 2 indexed citations

20.

Njølstad, Inger & Maja‐Lisa Løchen. (1998). Østrogen bør ikke brukes primærprofylaktisk mot hjerte- og karsykdom. Tidsskrift for Den Norske Laegeforening.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact